It’s not easy to get depression-detecting AI through the FDA

April 2, 2026 Robert Hart

A vintage computer on a background of 1s and 0s with a brain on the screen representing AI

For the past seven years, the California-based startup Kintsugi has been developing AI designed to detect signs of depression and anxiety from a person's speech. But after failing to secure FDA clearance in time, the company is shutting down and releasing most of its technology as open-source. Some elements may even find a second life beyond healthcare, like detecting deepfake audio.

Mental health assessments still largely rely on patient questionnaires and clinical interviews, rather than the lab tests or scans common in physical medicine. Instead of focusing on what someone is saying, Kintsugi's software analyzes how it is being said. Th …

Read the full story at The Verge.

Previous Article
Razer gaming accessories include a $25 Taco Bell gift card at Best Buy
Razer gaming accessories include a $25 Taco Bell gift card at Best Buy

Razer is summoning hungry gamers to Best Buy, where shoppers can get a free $25 Taco Bell gift card with th...

Next Article
Despite EV headwinds, Rivian’s sales are up
Despite EV headwinds, Rivian’s sales are up

It's rough out there for the pure EV companies, but despite all the challenges, Rivian says its on target f...